News

Life sciences

Octapharma receives approval to distribute drug in the USA

31. July 2023

Octapharma USA has received approval in the USA for its drug Balfaxar, which is marketed as Octaplex in Europe and Canada. Before surgery, the drug helps to rapidly restore blood clotting after this may have been suppressed following a heart attack.

Dividat collaborates with Pacific Neuroscience Institute

20. July 2023

The medtech company Dividat has entered into a collaboration agreement with the Pacific Neuroscience Institute based in California. The spin-off from the Swiss Federal Institute of Technology Zurich is providing its training device Dividat Senso for

Saiba Animal Health issues license to Boehringer Ingelheim

14. June 2023

German pharmaceutical company Boehringer Ingelheim has secured an exclusive license for a Saiba Animal Health product candidate. This is the second license agreement that Saiba, based in Pfäffikon in the canton of Schwyz, has executed this year.

Octapharma presents new information at congress in Canada

08. June 2023

Octapharma from the Swiss canton of Schwyz will be presenting new data from its portfolio products for hematology and intensive therapy at the upcoming ISTH 2023 Congress in Montreal. Furthermore, participants will also be informed about

Abiogen Pharma acquires majority stake in EffRx

30. May 2023

Abiogen, a pharmaceutical firm based in the Italian city of Pisa, has acquired a 97.09 percent stake in EffRx Pharmaceuticals. Since 2014, Abiogen has been responsible for distributing the most important drug of the specialist for musculoskeletal

Dividat becomes exclusive distributor for Tover

17. May 2023

MedTech company Dividat, located in the canton of Schwyz, has acquired exclusive distribution rights for the company Tover. The Tovertafel (or “Magic Table” in English) projects games for people with dementia or cognitive challenges from the

Swissbiomechanics celebrates 60-year anniversary

16. May 2023

On June 3, Swissbiomechanics is holding an open day at the Motion Innovation Center at its headquarters in Einsiedeln in the canton of Schwyz to celebrate its 60th anniversary. During this event, the specialist in tailored shoes and inserts as well

Dividat agrees partnership to make senso rehab device available globally

14. April 2023

THERA-Trainer, a brand of medica Medizintechnik GmbH based in the Upper Swabia region of Germany, is expanding its portfolio to include the senso training device developed by Dividat. As such, the cognitive-motor rehab device will now form part of a

Dividat claims ZURZACH Care Pionier Award

04. April 2023

Dividat has won the ZURZACH Care Pionier Award. The Schwyz-based spin-off from ETH Zurich specializes in the development of cognitive-motor training devices. ZURZACH Care established this award to mark the 50th anniversary of the company’s

Dividat hosts tech conference on healthy aging

22. March 2023

Dividat, a specialist in cognitive motor training devices and concepts based in the canton of Schwyz, is organizing a half-day symposium in the Volkshaus Zürich. Experts in geriatric medicine and care will discuss how such technologies can help

Octapharma records strong growth in 2022

21. February 2023

The Octapharma Group has posted new record values for sales, operating profit, pre-tax profit and net profit for the 2022 financial year. Sales rose by 13.7 percent to stand at 2.854 billion euros, while operating income came in at 522 million euros.

Oviva addresses psychotherapy

09. February 2023

The startup Oviva based in the Swiss canton of Schwyz plans to also work on psychotherapy in future. The digital medicine company has primarily developed program modules for nutritional advice to date.